Wanja Kildal
- Post doc; PhD
- (+47) 22 78 23 35
Publications 2023
Accounting for intensity variation in image analysis of large-scale multiplexed clinical trial datasets
J Pathol Clin Res, 9 (6), 449-463
DOI 10.1002/cjp2.342, PubMed 37697694
Pathogenetic Dichotomy in Angioleiomyoma
Cancer Genomics Proteomics, 20 (6), 556-566
DOI 10.21873/cgp.20405, PubMed 37889065
Publications 2022
Corrigendum to "Cabazitaxel-loaded Poly(2-ethylbutyl cyanoacrylate) nanoparticles improve treatment efficacy in a patient derived breast cancer xenograft", [Journal of Control Release, 293 (2019) 183-192]
J Control Release, 349, 1
DOI 10.1016/j.jconrel.2022.06.040, PubMed 35792388
Publications 2021
PTEN and DNA Ploidy Status by Machine Learning in Prostate Cancer
Cancers (Basel), 13 (17)
DOI 10.3390/cancers13174291, PubMed 34503100
Immune checkpoint B7-H3 protein expression is associated with poor outcome and androgen receptor status in prostate cancer
Prostate, 81 (12), 838-848
DOI 10.1002/pros.24180, PubMed 34125445
Biodistribution of Poly(alkyl cyanoacrylate) Nanoparticles in Mice and Effect on Tumor Infiltration of Macrophages into a Patient-Derived Breast Cancer Xenograft
Nanomaterials (Basel), 11 (5)
DOI 10.3390/nano11051140, PubMed 33924869
Stress-Mediated Reprogramming of Prostate Cancer One-Carbon Cycle Drives Disease Progression
Cancer Res, 81 (15), 4066-4078
DOI 10.1158/0008-5472.CAN-20-3956, PubMed 34183356
Breast cancer metastasis: immune profiling of lymph nodes reveals exhaustion of effector T cells and immunosuppression
Mol Oncol, 16 (1), 88-103
DOI 10.1002/1878-0261.13047, PubMed 34165864
Publications 2019
Prognostic value of mitotic checkpoint protein BUB3, cyclin B1, and pituitary tumor-transforming 1 expression in prostate cancer
Mod Pathol, 33 (5), 905-915
DOI 10.1038/s41379-019-0418-2, PubMed 31801961
Tumour-infiltrating CD8+ lymphocytes and colorectal cancer recurrence by tumour and nodal stage
Br J Cancer, 121 (6), 474-482
DOI 10.1038/s41416-019-0540-4, PubMed 31388185
Correction: Tumour-infiltrating CD8+ lymphocytes and colorectal cancer recurrence by tumour and nodal stage
Br J Cancer, 121 (9), 807
DOI 10.1038/s41416-019-0590-7, PubMed 31548598
Publications 2018
Cabazitaxel-loaded Poly(2-ethylbutyl cyanoacrylate) nanoparticles improve treatment efficacy in a patient derived breast cancer xenograft
J Control Release, 293, 183-192
DOI 10.1016/j.jconrel.2018.11.029, PubMed 30529259
Publications 2017
Tumour heterogeneity poses a significant challenge to cancer biomarker research
Br J Cancer, 117 (3), 367-375
DOI 10.1038/bjc.2017.171, PubMed 28618431
[Properties of cancer cell DNA affects the prognosis]
Tidsskr Nor Laegeforen, 137 (19)
DOI 10.4045/tidsskr.16.0966, PubMed 29043733
Characteristics of tumor cell DNA affect prognosis
Tidsskr. Nor. Laegeforen., 137 (19), 1519-1523
Publications 2016
Changes in Chromatin Structure in Curettage Specimens Identifies High-Risk Patients in Endometrial Cancer
Cancer Epidemiol Biomarkers Prev, 26 (1), 61-67
DOI 10.1158/1055-9965.EPI-16-0215, PubMed 27587790
Cancer Prognosis Defined by the Combined Analysis of 8q, PTEN and ERG
Transl Oncol, 9 (6), 575-582
DOI 10.1016/j.tranon.2016.08.005, PubMed 27916292
Publications 2015
DNA ploidy in curettage specimens identifies high-risk patients and lymph node metastasis in endometrial cancer
Br J Cancer, 112 (10), 1656-64
DOI 10.1038/bjc.2015.123, PubMed 25897678
Publications 2014
Entropy-based adaptive nuclear texture features are independent prognostic markers in a total population of uterine sarcomas
Cytometry A, 87 (4), 315-25
DOI 10.1002/cyto.a.22601, PubMed 25483227
Publications 2012
The prognostic value of adaptive nuclear texture features from patient gray level entropy matrices in early stage ovarian cancer
Anal Cell Pathol (Amst), 35 (4), 305-14
DOI 10.3233/ACP-2012-0065, PubMed 22596183
Publications 2011
Genomic imbalances in endometrial adenocarcinomas - comparison of DNA ploidy, karyotyping and comparative genomic hybridization
Mol Oncol, 6 (1), 98-107
DOI 10.1016/j.molonc.2011.10.002, PubMed 22062770
Publications 2010
DNA ploidy as a prognostic marker in selected gynecological malignancies
In Series of dissertations submitted to the Faculty of Medicine, University of Oslo, Unipub, Oslo, no. 960, 1 b. (flere pag.)
BIBSYS 101339887, ISBN 978-82-8072-493-9
DNA ploidy heterogeneity in endometrial carcinoma: comparison between curettage and hysterectomy specimens
Int J Gynecol Pathol, 29 (6), 572-8
DOI 10.1097/PGP.0b013e3181e2e8ee, PubMed 20881853
Publications 2009
The prognostic value of DNA ploidy in a total population of uterine sarcomas
Ann Oncol, 20 (6), 1037-41
DOI 10.1093/annonc/mdn765, PubMed 19201782
Beta-catenin expression in uterine sarcomas and its relation to clinicopathological parameters
Eur J Cancer, 45 (13), 2412-7
DOI 10.1016/j.ejca.2009.06.017, PubMed 19622417
Publications 2007
Molecular based treatment of oral cancer (Retraction of vol 39, pg 749, 2003)
Oral Oncol., 43 (4), 421
DOI 10.1016/j.oraloncology.2007.01.004
Abnormal DNA content predicts the occurrence of carcinomas in non-dysplastic oral white patches (Retraction of vol 37, pg 558, 2001)
Oral Oncol., 43 (4), 418
DOI 10.1016/j.oraloncology.2007.01.001
Cyclooxygenase-2 (COX-2) expression in high-risk premalignant oral lesions (Retraction of vol 39, pg 497, 2003)
Oral Oncol., 43 (4), 420
DOI 10.1016/j.oraloncology.2007.01.003
Publications 2005
beta-catenin expression, DNA ploidy and clinicopathological features in ovarian cancer: a study in 253 patients
Eur J Cancer, 41 (8), 1127-34
DOI 10.1016/j.ejca.2005.01.022, PubMed 15911235
Non-steroidal anti-inflammatory drugs and the risk of oral cancer: a nested case-control study
Lancet, 366 (9494), 1359-66 (Retracted)
DOI 10.1016/S0140-6736(05)67488-0, PubMed 16226613
Publications 2004
Evaluation of genomic changes in a large series of malignant ovarian germ cell tumors--relation to clinicopathologic variables
Cancer Genet Cytogenet, 155 (1), 25-32
DOI 10.1016/j.cancergencyto.2004.02.010, PubMed 15527899
The influence of resection and aneuploidy on mortality in oral leukoplakia
N Engl J Med, 350 (14), 1405-13 (Retracted)
DOI 10.1056/NEJMoa033374, PubMed 15070790
Publications 2003
Genome profiles of bilateral dysgerminomas, a unilateral gonadoblastoma, and a metastasis from a 46, XY phenotypic female
Hum Pathol, 34 (9), 946-9
DOI 10.1016/s0046-8177(03)00345-9, PubMed 14562293
Large-scale genomic instability predicts long-term outcome for women with invasive stage I ovarian cancer
Ann Oncol, 14 (10), 1494-500
DOI 10.1093/annonc/mdg403, PubMed 14504048
Molecular based treatment of oral cancer
Oral Oncol, 39 (8), 749-58 (Retracted)
DOI 10.1016/s1368-8375(03)00098-8, PubMed 13679198
Cyclooxygenase-2 (COX-2) expression in high-risk premalignant oral lesions
Oral Oncol, 39 (5), 497-505 (Retracted)
DOI 10.1016/s1368-8375(03)00012-5, PubMed 12747975
Publications 2002
Gross genomic aberrations in precancers: clinical implications of a long-term follow-up study in oral erythroplakias
J Clin Oncol, 20 (2), 456-62
DOI 10.1200/JCO.2002.20.2.456, PubMed 11786574
Publications 2001
Prognostic classification of early ovarian cancer based on very low dimensionality adaptive texture feature vectors from cell nuclei from monolayers and histological sections
Anal Cell Pathol, 23 (2), 75-88
DOI 10.1155/2001/683747, PubMed 11904463
Comparison of histological grading and large-scale genomic status (DNA ploidy) as prognostic tools in oral dysplasia
J Pathol, 194 (3), 303-10 (Retracted)
DOI 10.1002/1096-9896(200107)194:3<303::AID-PATH879>3.0.CO;2-Q, PubMed 11439362
DNA content as a prognostic marker in patients with oral leukoplakia
N Engl J Med, 344 (17), 1270-8 (Retracted)
DOI 10.1056/NEJM200104263441702, PubMed 11320386
Abnormal DNA content predicts the occurrence of carcinomas in non-dysplastic oral white patches
Oral Oncol, 37 (7), 558-65 (Retracted)
DOI 10.1016/s1368-8375(00)00126-3, PubMed 11564576
Publications 2000
[Digital image analysis in pathology--exemplified in prostatic cancer]
Tidsskr Nor Laegeforen, 120 (4), 479-88
PubMed 10833941
Publications 1996
Meth A sarcom celler fører til selektiv nedregulering av MHC klasse II varianten I-A₃ og modulering av cytokin frigjøring fra peritoneale makrofager, in vitro
Institutt for medisinsk biologi, Universitetet i Tromsø, Tromsø, IX, 70 s.
BIBSYS 970276664